Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Inflamm Bowel Dis

Search In Journal Title:

Abbravation: Inflammatory Bowel Diseases

Search In Journal Abbravation:

Publisher

Narnia

Search In Publisher:

DOI

10.1007/s004600050274

Search In DOI:

ISSN

1078-0998

Search In ISSN:
Search In Title Of Papers:

Dangers associated with endoscopic management of s

Authors: Koltun Walter A
Publish Date: 2007/03/01
Volume: 13, Issue: 3, Pages: 359-361
PDF Link

Abstract

A clear cause and cure for Crohns disease CD continues to elude caregivers and researchers alike much to the frustration of these frequently youthful and usually very symptomatic patients The experienced clinician recognizes that he or she is frequently treating only the complications of CD and not the disease itself Thus drugs are used to quell mucosal inflammation and to treat foci of sepsis fistuli and abscesses without knowing what is actually causing the inflammation or abscessesOne of the most symptomatic of CD complications is intestinal obstruction brought about by either severe inflammation compromising the lumen of the bowel or a fibrotic stricture the result of “burnt out” inflammation and scarring Such bowel obstruction can present as an acute emergency but more often is manifest as recurrent crampy abdominal pain aggravated by oral intake especially of highfiber foods Twenty


Keywords:

References

citation journal title=Dis Colon Rectum citation year=2002 citation volume=45 citation pages=15951600


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Gender and Location of CRC in IBDImplications for Surveillance Protocols
  2. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent
  3. Targeting TNF in Postoperative Recurrence of Crohn's Disease:Can We Extinguish the Fire Before It Starts?
  4. Gene Expression Profiling Identifies Mechanisms of Protection to Recurrent Trinitrobenzene Sulfonic Acid Colitis Mediated by Probiotics
  5. Adalimumab Therapy in Crohn's Disease of the Ileal Pouch
  6. Observations on Severity and Activity Indices in a Therapeutic Trial of Active Crohn's Disease
  7. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab
  8. One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis
  9. Role of diet in the development of inflammatory bowel disease
  10. Thromboembolism in pediatric inflammatory bowel disease: Systematic review
  11. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  12. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  13. Twin Studies Reveal Specific Imbalances in the Mucosaassociated Microbiota of Patients with Ileal Crohn's Disease
  14. Microbial Causation of the Chronic Idiopathic Inflammatory Bowel Diseases
  15. Babesiosis in a Patient on Infliximab for Crohn's Disease
  16. Plasma Chromogranin A in Patients With Inflammatory Bowel Disease: A Possible Explanation
  17. Effect of Adalimumab on Clinical Laboratory Parameters in Patients with Crohn's Disease: Results from the CHARM Trial
  18. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease
  19. What is the incidence, prevalence, and natural history of indeterminate colitis?
  20. Anti-tumor Necrosis Factor and Postoperative Complications in Crohn's Disease: Systematic Review and Meta-analysis
  21. Effects of T cell-induced colonic inflammation on epithelial barrier function†
  22. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients
  23. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis
  24. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease†
  25. Role of the interleukin 24 in patients with ulcerative colitis
  26. Antibodies Against Cyclic Citrullinated Peptide (CCP) in Inflammatory Bowel Disease Patients With or Without Arthritic Manifestations
  27. Nitric Oxide and Colitis: Rats, Humans and Now Macaques
  28. Distinct Microbiome in Pouchitis Compared to Healthy Pouches in Ulcerative Colitis and Familial Adenomatous Polyposis
  29. Is Crohn's creeping fat an adipose tissue?
  30. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease
  31. Cyclosporine in the management of severe ulcerative colitis while breast-feeding
  32. Nailing down the shingles in IBD
  33. Local Injection of Infliximab in Symptomatic Isolated Mucosal LesionsA Novel Scenario for Endoscopic Therapy?
  34. A New Type of Strictureplasty for the Treatment of Multiple Long Stenosis in Crohn's Disease

Search Result: